Policy and Strategies for Control of Chronic Hepatitis B in Korea

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:gongfangqing
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Hepatitis B infection is a major etiology of acute and chronic hepatitis,cirrhosis,and hepatocellular carcinoma(HCC) in Korea,suggesting that HBV infection greatly affects public health of Korea.Currently,hepatitis B infection is currently classified as one of the groups of infectious disease designated by law and is addressed by national vaccination programs in Korea.
其他文献
Background:The nuclear factor of activated T-cells,cytoplasmic 3(NFATC3)belongs to a family of transcription factors that can orchestrate an effective immune response mainly in T cells.But the functio
会议
Background:Acute-on-chronic liver failure(ACLF)caused by hepatitis B virus(HBV)is a severe disease with high mortality.We aimed to develop a survival model for HBV-related ACLF based on dynamic change
会议
Background:Hepatitis B virus(HBV)infection is still a worldwide disease which may cause liver cirrhosis or even hepatocellular carcinoma.Lamivudine is a potent nucleoside analogue used in treating chr
会议
Background:A retrospective one-center study was conducted to assess the information of bile culture and susceptibility testing special for malignant biliary obstruction and to get the risk factors of
会议
Background:To investigate the integration role of hepatitis B virus(HBV)on human hepatocellular carcinoma(HCC)cell lines Methods:HCC cell lines from patients with HBV infection(MHCC97H,MHCC97L,MHCCLM3
会议
Background:To investigate the evolution of hepatitis B virus(HBV)quasispecies(QS)within the covalently closed circular viral DNA(cccDNA)Polymerase(P)region in hepatocyte during the stage of meeting th
会议
Background:The interplay of virus/host proteins mediates the hepatitis B virus(HBV) infection.Host factors may provide new targets for the antiviral therapy of HBV infection.Autophagy plays a vital ro
会议
Objective:To evaluate the antiviral efficacy and safety of telbivudine(LDT) and entecavir(ETV) in patients with chronic hepatitis B(CHB) after IFN treatment failure.
会议
Aims:This study aimed to compare virological response of entecavir monotherapy and de novo lamivudine plus adefovir combination therapy in chronic hepatitis B(CHB) patients with high viral load.
会议
Objective:To investigate whether the prognostic simple model for evaluating patients with severe hepatitis based on platelet and hepatic function be of practical value.
会议